SYNLAB UK & Ireland:

Official Notice – Long-haul COVID Testing

Published: 12th March 2022

Update on SYNLAB position re: long-haul COVID testing services in the UK

With events unfolding in the last few hours, we are issuing this independent statement aimed at people affected by this week’s issues, as well as those suffering from long-term COVID-related illnesses. At SYNLAB, we are unwavering in our commitment to providing high quality testing and diagnostic services which centre’s on the needs of people and consumers, and we pride ourselves on our professionalism and integrity.

We re-emphasise our earlier statement that SYNLAB did not at any time agree to, support or endorse the clinic being arranged on Monday 14 March in Bristol by another party. At the point at which clinics were promoted in our name and without our consent, discussions were still very much under way about how we could put in place arrangements which meet the necessary standards and regulations. It may seem like a simple thing to achieve, but setting up a service which is safe, legitimate and effective can take weeks, if not months – especially when it needs to involve multiple organisations, which is the case for this particular test.

We very much regret the distress that all of this will have caused to people affected by long-term COVID illnesses, particularly those whose hopes were raised about taking the test in the UK next week.

With this community in mind, SYNLAB remains committed to doing everything we can to support the introduction of long-COVID testing in the UK; and we are wholly supportive and encouraging of other organisations who may be able to introduce this particular testing service instead. Our primary concern is for this vulnerable group of people, it is not one of commercial interest.

I would add that we had been making good progress in exploring a possible solution in collaboration with other parties, and we will continue our discussions within SYNLAB.

What has happened over the last week has been very disappointing for all of us at SYNLAB – as we know it will have been for those struggling with long-term COVID illnesses. Developing testing services to help diagnose and treat chronic illness associated with COVID is a truly important mission, and one which we wholeheartedly support.

Mark Dollar
Chief Executive
SYNLAB UK & Ireland

Mark Dollar
Latest SYNLAB UK & Ireland News
SYNLAB ESG Report 2021

Published: 17th May 2022 SYNLAB UK & Ireland’s Environmental, Social and Governance (ESG) Roadmap and Framework is now available to read here. Please click on…

Read More (about 'SYNLAB ESG Report 2021')
SYNLAB UK & Ireland to showcase biomedical science career opportunities during IBMS Congress

Published: 10th March 2022 Leading pathology provider SYNLAB UK & Ireland is looking forward to welcoming biomedical scientists to its stand at the IBMS Congress…

Read More (about 'SYNLAB UK & Ireland to showcase biomedical science career opportunities during IBMS Congress')
International Day of Women and Girls in Science

Published: 11th February 2022 In celebration of International Day of Women and Girls in Science, we are delighted to unveil a series of short interviews…

Read More (about 'International Day of Women and Girls in Science')
Ground-breaking Veterinary Digital Pathology Service

Published: 28th September 2021 Ground-breaking Veterinary Digital Pathology Service set to Revolutionise Pet Care Across Finland and other Nordic countries A ground-breaking service that enables…

Read More (about 'Ground-breaking Veterinary Digital Pathology Service')
GENDER Pay Gap Report 2020-21

Published: 21st September 2021 A Message From Our CEO Whilst we are pleased at the improvement in our gender pay gap over the past four…

Read More (about 'GENDER Pay Gap Report 2020-21')
Customer Centricity, People and Innovation: The Secret to VPG’s 20 Years’ Success

Published: 1st July 2021 The Veterinary Pathology Group (VPG), a member of SYNLAB UK and Ireland today announced that it is celebrating its 20th anniversary….

Read More (about 'Customer Centricity, People and Innovation: The Secret to VPG’s 20 Years’ Success')
Modern Slavery & Human Trafficking Statement 2021

Published: 28th June 2021 Introduction This is the SYNLAB Group’s Modern Slavery and Human Trafficking Statement under Section 54 of the UK Modern Slavery Act…

Read More (about 'Modern Slavery & Human Trafficking Statement 2021')
SYNLAB Goes Public

Published: 30th April 2021 We are proud to announce that SYNLAB is now listed on the Frankfurt Stock Exchange. This historical milestone is built on…

Read More (about 'SYNLAB Goes Public')